Hematological Neoplasms

• CLINICAL_TRIALS research · 2025-07-25
  Clinical Trial Update: Distraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies [NA]

  Clinical trial update about using virtual reality distraction to reduce pain and anxiety for patients with hematological malignancies; the s…

• CLINICAL_TRIALS research · 2025-03-30
  Clinical Trial Update: Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease [Phase 4]

  Phase 4 clinical trial update evaluating dose individualization of antineoplastic and anti-infective drugs in children with hematological ne…

• CLINICAL_TRIALS trial_result · 2023-03-16
  Clinical Trial Update: Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT [Phase 2, Phase 3]

  A Phase 2/3 clinical trial of pegylated interferon alpha-2b for relapsed hematological malignancies after allogeneic hematopoietic stem cell…

• CLINICAL_TRIALS trial_result · 2015-09-09
  Clinical Trial Update: Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia

  This clinical trial update reports on the use of granulocyte transfusions in hematologic patients with febrile neutropenia, and the study ha…

• CLINICAL_TRIALS trial_result · 2014-01-14
  Clinical Trial Update: VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

  A post-authorization study (VALEO) update evaluating the safety and effectiveness of bortezomib in the Netherlands has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.